Publication | Closed Access

The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product

Regenerative MedicineAdverse EventsBone Marrow FailureMarrow TransplantationGranulocyteMedicineLeukapheresis ProductStem Cell TransplantationHematologyImmunologyPathologyStem Cell ResearchAutoimmunityCell TransplantationStem CellsCell BiologyMyelopoiesisHealth Sciences